• 1
    U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999-2004 Incidence and Mortality Web-based Report. Available at: Accessed on February 11, 2008.
  • 2
    ACOG Committee on Practice Bulletins. ACOG Practice Bulletin: clinical management guidelines for obstetrician-gynecologists. Number 45, August 2003. Cervical cytology screening (replaces committee opinion 152, March 1995). Obstet Gynecol. 2003; 102: 417427.
  • 3
    Saslow D,Runowicz CD,Solomon D, et al. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin. 2002; 52: 342362.
  • 4
    U.S. Preventive Services Task Force. Screening for cervical cancer: recommendations and rationale. Available at: Accessed on May 2, 2006.
  • 5
    Wright TCJr,Massad LS,Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007; 197: 346355.
  • 6
    Wright TCJr,Massad LS,Dunton CJ, et al. 2006 consensus guidelines for the management of women with cervical intraepithelial neoplasia or adenocarcinoma in situ. Am J Obstet Gynecol. 2007; 197: 340345.
  • 7
    Markowitz LE,Dunne EF,Saraiya M, et al. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56: 124.
  • 8
    Saslow D,Castle PE,Cox JT, et al. American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin. 2007; 57: 728.
  • 9
    Lansky A,Sullivan PS,Gallagher KM,Fleming PL. HIV behavioral surveillance in the U.S.: a conceptual framework. Public Health Rep. 2007; 122: 1623.
  • 10
    Greenberg RS,Daniel SR,Flanders WD,Eley JW,Boring JR. Medical Epidemiology. 2nd ed. Stamford, CT: Appleton & Lange; 1996.
  • 11
    Centers for Disease Control and Prevention. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR Morb Mortal Wkly Rep. 2001; 50: 135.
  • 12
    Link BG,Northridge ME,Phelan JC,Ganz ML. Social epidemiology and the fundamental cause concept: on the structuring of effective cancer screens by socioeconomic status. Milbank Q. 1998; 76: 375402.
  • 13
    Akers AY,Newmann SJ,Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer. 2007; 31: 157181.
  • 14
    Saraiya M,Ahmed F,Krishnan S,Richards TB,Unger ER,Lawson HW. Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol. 2006; 109: 360370.
  • 15
    Benard V,Coughlin SS,Thompson T,Richardson LC. Cervical cancer incidence in the United States by area of residence, 1998 2001. Obstet Gynecol. 2007; 110: 681686.
  • 16
    Lawson HW,Lee NC,Thames SF,Henson R,Miller DS. Cervical cancer screening among low-income women: results of a national screening program, 1991-1995. Obstet Gynecol. 1998; 92: 745752.
  • 17
    Benard VB,Eheman CR,Lawson HW, et al. Cervical screening in the National Breast and Cervical Cancer Early Detection Program, 1995-2001. Obstet Gynecol. 2004; 103: 564571.
  • 18
    Keeter S,Miller C,Kohut A,Groves R,Presser S. Consequences of reducing nonresponse in a large national telephone survey. Public Opin Q. 2000; 64: 125148.
  • 19
    Council of American Survey Research Organizations. On the Definition of Response Rates: A Special Report of the CASRO Task Force on Completion Rates. Available at: Accessed on October 28, 2007.
  • 20
    The American Association for Public Opinion Research. Standard Definitions: Final Dispositions of Case Codes and Outcome Rates for Surveys. 4th ed. Lenexa, KS: American Association for Public Opinion Research; 2006.
  • 21
    Curtin R,Presser S,Singer E. Changes in telephone survey nonresponse over the past quarter century. Public Opin Q. 2005; 69: 8798.
  • 22
    Tucker C,Brick JM,Meekins B. Household telephone service and usage patterns in the U.S. in 2004: implications for telephone samples. Presented at: annual Association for Public Opinion Research Conference, May 12-15, 2005, Miami, Florida.
  • 23
    Tourangeau R. Survey research and societal change. Annu Rev Psychol. 2004; 55: 775801.
  • 24
    Link MW,Battaglia MP,Frankel MR,Osborn L,Mokdad AH. Reaching the U.S. cell phone generation: comparison of cell phone survey results with an ongoing landline telephone survey. Public Opin Q. 2007; 71: 814839.
  • 25
    Gardner BR,Strickland MJ,Correa A. Application of the automated spatial surveillance program to birth defects surveillance data. Birth Defects Res A Clin Mol Teratol. 2007; 79: 559564.
  • 26
    Hughes E,McCracken M,Roberts H, et al. Surveillance for certain health behaviors among states and selected areas — Behavioral Risk Factor Surveillance System, United States, 2004. MMWR Surveill Summ. 2006; 55: 1124.
  • 27
    Coughlin SS,King J,Richards TB,Ekwueme DU. Cervical cancer screening among women in metropolitan areas of the United States by individual-level and area-based measures of socioeconomic status, 2000 to 2002. Cancer Epidemiol Biomarkers Prev. 2006; 15: 21542159.
  • 28
    Schootman M,Jeffe DB,Baker EA,Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006; 60: 202207.
  • 29
    Wingo PA,Howe HL,Thun MJ, et al. A national framework for cancer surveillance in the United States. Cancer Causes Control. 2005; 16: 151170.
  • 30
    Klabunde CN,Vernon SW,Nadel MR,Breen N,Seeff LC,Brown ML. Barriers to colorectal cancer screening: a comparison of reports from primary care physicians and average risk adults. Med Care. 2005; 43: 939944.
  • 31
    Kellerman SE,Herold J. Physician response to surveys. A review of the literature. Am J Prev Med. 2001; 20: 6167.
  • 32
    Yeazel MW,Lindstrom Bremer KM,Center BA. A validated tool for gaining insight into clinicians' preventive medicine behaviors and beliefs: the preventive medicine attitudes and activities questionnaire (PMAAQ). Prev Med. 2006; 43: 8691.
  • 33
    Puleo E,Zapka JG,Goins KV, et al. Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof. 2005; 28: 310327.
  • 34
    Insinga RP,Glass AG,Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004; 191: 105113.
  • 35
    Negoita S,Harrison JN,Qiao B,Ekwueme DU,Flowers LC,Khan AR. Distribution of treatment for HPV-associated gynecologic carcinomas prior to prophylactic vaccine. Cancer. 2008; 113( 10 suppl): 2926-2935.
  • 36
    Burchell AN,Winer RL,de Sanjose S,Franco EL. Chapter 6: epidemiology and transmission dynamics of genital HPV infection. Vaccine. 2006; 24: S52S61.
  • 37
    Koutsky LA,Harper DM. Chapter 13: current findings from prophylactic HPV vaccine trials. Vaccine. 2006; 24: S114S121.
  • 38
    Hildesheim A,Herrero R,Wacholder S, et al. Effect of human papillomavirus 16/18 L1 viruslike particle vaccine among young women with preexisting infection: a randomized trial. JAMA. 2007; 298: 743753.
  • 39
    Eaton DK,Kann L,Kinchen S, et al. Youth risk behavior surveillance—United States, 2005. MMWR Surveill Summ. 2006; 55: 1108.
  • 40
    Joseph D,Miller J,Wu X-C, et al. Understanding the burden of HPV-associated anal cancers in the United States. Cancer. 2008; 113( 10 suppl): 28922900.
  • 41
    Nelson DE,Holtzman D,Bolen J,Stanwyck CA,Mack KA. Reliability and validity of measures from the Behavioral Risk Factor Surveillance System (BRFSS). Soc Prev Med. 2001; 46: S03S42.
  • 42
    Bolton P,Holt E,Ross A,Hughart N,Guyer B. Estimating vaccination coverage using parental recall, vaccination cards, and medical records. Public Health Rep. 1998; 113: 521526.
  • 43
    Czaja C,Crossette L,Metlay JP. Accuracy of adult reported pneumococcal vaccination status of children. Ann Epidemiol. 2005; 15: 253256.
  • 44
    Fishbein DB,Willis BC,Cassidy WM, et al. Determining indications for adult vaccination: patient self-assessment, medical record, or both? Vaccine. 2006; 24: 803818.
  • 45
    Zimmerman RK,Raymund M,Janosky JE,Nowalk MP,Fine MJ. Sensitivity and specificity of patient self-report of influenza and pneumococcal polysaccharide vaccinations among elderly outpatients in diverse patient care strata. Vaccine. 2003; 21: 1491.
  • 46
    Stokley S,Rodewald LE,Maes EF. The impact of record scattering on the measurement of immunization coverage. Pediatrics. 2001; 107: 9196.
  • 47
    Bloom B,Dey AN,Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2005. Vital Health Statistics 10. 2006; 231: 184.
  • 48
    Gordon TE,Zook EG,Averhoff FM,Williams WW. Consent for adolescent vaccination: issues and current practices. J School Health. 1997; 67: 259264.
  • 49
    Kinsey AC,Pomeroy WB,Martin CE. Sexual Behavior in the Human Male. Philadelphia: WB Saunders; 1948: 1804.
  • 50
    Kinsey AC,Pomeroy WB,Martin CE,Gebhard PH. Sexual Behavior in the Human Female. Philadelphia: WB Saunders; 1953: 1842.
  • 51
    Jaccard J,McDonald R,Wan CK,Guilamo-Ramos V,Dittus P,Quinlan S. Recalling sexual partners: the accuracy of self-reports. J Health Psychol. 2004; 9: 699712.
  • 52
    Kauth MR,St. Lawrence JS,Kelly JA. Reliability of retrospective assessments of sexual HIV risk behavior: a comparison of biweekly, 3-month, and 12-month self-reports. AIDS Educ Prev. 1991; 3: 207214.
  • 53
    Dunne EF,Unger ER,Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007; 297: 813819.
  • 54
    Zenilman JM,Weisman CS,Rompalo AM, et al. Condom use to prevent incident STDs: the validity of self-reported condom use. Sex Transm Dis. 1995; 22: 1521.
  • 55
    Peterman TA,Lin LS,Newman DR, et al. Does measured behavior reflect STD risk? An analysis of data from a randomized controlled behavioral intervention study. Project RESPECT Study Group. Sex Transm Dis. 2000; 27: 446451.
  • 56
    Weinhardt LS,Forsyth AD,Carey MP,Jaworski BC,Durant LE. Reliability and validity of self-report measures of HIV-related sexual behavior: progress since 1990 and recommendations for research and practice. Arch Sex Behav. 1998; 27: 155180.
  • 57
    Freeman HP,Wingrove BK. Excess Cervical Cancer Mortality: A Marker for Low Access to Health Care in Poor Communities. Rockville, MD: National Cancer Institute, Center to Reduce Cancer Health Disparities; 2005.
  • 58
    Janerich DT,Hadjimichael OC,Schwartz PE, et al. The screening histories of women with invasive cervical cancer, Connecticut. Am J Public Health. 1995; 85: 791794.
  • 59
    Hewitt M,Devesa SS,Breen N. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey. Prev Med. 2004; 39: 270278.
  • 60
    Solomon D,Breen N,McNeel T. Cervical cancer screening rates in the United States and the potential impact of implementation of screening guidelines. CA Cancer J Clin. 2007; 57: 105111.
  • 61
    Solomon D,Schiffman M,Castle P,Jeronimo J. Predicting the effect of successful HPV vaccination on existing U.S. cervical screening programs. Cancer. 2008; 113( suppl).
  • 62
    Vernon SW,Briss P,Tiro JA,Warnecke RB. Some methodologic lessons learned from cancer screening research. Cancer. 2004; 101: 11311145.
  • 63
    Partin MR,Casey-Paal AL,Slater JS,Korn JE. Measuring mammography compliance: Lessons learned from a survival analysis of screening behavior. Cancer Epidemiol Biomarkers Prev. 1998; 7: 681687.
  • 64
    Rakowski WA,Breen NL,Meissner HI, et al. Prevalence and correlates of repeat mammography among women aged 55-79 in the year 2000 National Health Interview Survey. Prev Med. 2004; 39: 110.
  • 65
    Stein AD,Lederman RI,Shea S. Reproducibility of the women's module of the Behavioral Risk Factor Surveillance System questionnaire. Ann Epidemiol. 1996; 6: 4752.
  • 66
    Brownson RC,Jackson-Thompson J,Wilkerson JC,Kiani F. Reliability of information on chronic disease risk factors collected in the Missouri Behavioral Risk Factor Surveillance System. Epidemiology. 1994; 5: 545549.
  • 67
    Warnecke RB,Sudman S,Johnson TP,O'Rourke D,Davis AM,Jobe JB. Cognitive aspects of recalling and reporting health-related events: Papanicolaou smears, clinical breast examinations, and mammograms. Am J Epidemiol. 1997; 146: 982992.
  • 68
    Pasick RJ,Stewart S,Bird JA,D'Onofrio CN. Quality of data in multiethnic health surveys. Public Health Rep. 2001; 116( suppl 1): 223243.
  • 69
    Crane LA,Kaplan CP,Bastani R,Scrimshaw SCM. Determinants of adherence among health department patients referred for a mammogram. Women Health. 1996; 24: 4364.
  • 70
    Fiscella K,Holt K,Meldrum S,Franks P. Disparities in preventive procedures: comparisons of self-report and Medicare claims data. BMC Health Serv Res. 2006; 6: 122.
  • 71
    Vernon SW,Meissner HI,Klabunde CN, et al. Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research. Cancer Epidemiol Biomarkers Prev. 2004; 13: 898905.
  • 72
    Schiffman M. Integration of human papillomavirus vaccination, cytology, and human papillomavirus testing. Cancer (Cancer Cytopathol). 2007; 111: 145153.
  • 73
    Irwin K,Montano D,Kasprzyk D, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006; 108: 397409.
  • 74
    Jain N,Irwin KL,Montano D, et al. Family physicians' knowledge of genital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med. 2006; 38: 483489.
  • 75
    Santelli JS,Lindberg LD,Abma J,McNeely CS,Resnick M. Adolescent sexual behavior: estimates and trends from 4 nationally representative surveys. Fam Plan Perspect. 2000; 32: 156165.
  • 76
    Santelli JS,Abma J,Ventura S, et al. Can changes in sexual behaviors among high school students explain the decline in teen pregnancy rates in the 1990s? J Adolesc Health. 2004; 35: 8090.
  • 77
    Shrier LA,Crosby R. Correlates of sexual experience among a national representative sample of alternative high school students. J School Health. 2003; 73: 197200.
  • 78
    Zapka JG,Puleo E,Taplin SH, et al. Processes of care in cervical and breast cancer screening and follow-up—the importance of communication. Prev Med. 2004; 39: 8190.
  • 79
    Jain N,Irwin K,Carlin L,Freeman C,Montano D,Kasprzyk D. Use of DNA tests for human papillomavirus infection by US clinicians, 2004. J Infect Dis. 2007; 196: 7681.
  • 80
    Saraiya M,Irwin KL,Carlin L, et al. Cervical cancer screening and management practices among providers in the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Cancer. 2007; 110: 10241032.
  • 81
    Binswanger IA,White MC,Perez-Stable EJ,Goldenson J,Tulsky JP. Cancer screening among jail inmates: frequency, knowledge, and willingness. Am J Public Health. 2005; 95: 17811787.
  • 82
    Hiatt RA,Klabunde CN,Breen NL,Swan J,Ballard-Barbash R. Cancer screening practices from National Health Interview Surveys: past present, and future. J Natl Cancer Inst. 2002; 94: 18371846.
  • 83
    Constantine NA,Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health. 2007; 40: 108115.
  • 84
    Saraiya M,Goodman MT,Datta D,Chen VW,Wingo PA. Cancer registries and monitoring the impact of prophylactic HPV vaccines: potential role. Cancer. 2008; 113( 10 suppl): 30473057.